Frontiers in Microbiology (Mar 2023)

Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2

  • Anthony T. Le,
  • Manhong Wu,
  • Afraz Khan,
  • Nicholas Phillips,
  • Pranav Rajpurkar,
  • Megan Garland,
  • Kayla Magid,
  • Mamdouh Sibai,
  • ChunHong Huang,
  • Malaya K. Sahoo,
  • Raffick Bowen,
  • Raffick Bowen,
  • Tina M. Cowan,
  • Tina M. Cowan,
  • Benjamin A. Pinsky,
  • Benjamin A. Pinsky,
  • Benjamin A. Pinsky,
  • Catherine A. Hogan,
  • Catherine A. Hogan,
  • Catherine A. Hogan,
  • Catherine A. Hogan

DOI
https://doi.org/10.3389/fmicb.2022.1059289
Journal volume & issue
Vol. 13

Abstract

Read online

IntroductionThe routine clinical diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely restricted to real-time reverse transcription quantitative PCR (RT-qPCR), and tests that detect SARS-CoV-2 nucleocapsid antigen. Given the diagnostic delay and suboptimal sensitivity associated with these respective methods, alternative diagnostic strategies are needed for acute infection.MethodsWe studied the use of a clinically validated liquid chromatography triple quadrupole method (LC/MS–MS) for detection of amino acids from plasma specimens. We applied machine learning models to distinguish between SARS-CoV-2-positive and negative samples and analyzed amino acid feature importance.ResultsA total of 200 samples were tested, including 70 from individuals with COVID-19, and 130 from negative controls. The top performing model overall allowed discrimination between SARS-CoV-2-positive and negative control samples with an area under the receiver operating characteristic curve (AUC) of 0.96 (95%CI 0.91, 1.00), overall sensitivity of 0.99 (95%CI 0.92, 1.00), and specificity of 0.92 (95%CI 0.85, 0.95).DiscussionThis approach holds potential as an alternative to existing methods for the rapid and accurate diagnosis of acute SARS-CoV-2 infection.

Keywords